SARAH CARPENTER: Open Payments
NPI 1023609252 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 12 payments from 8 companies in 2025. Trend: 2023 $712 · 2024 $772 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 2 | $34 |
| Amgen Inc. | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $33 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Stryker Corporation | 1 | $16 |
Products named: VERQUVO, REPATHA, Kerendia, LEQVIO, LifeVest, ONPATTRO, EVKEEZA, FLOWTRIEVER CATHETER, S.
Industry payments across IN — which companies pay providers there.
